Nutrimetabolomics and Adipocitokines in the "Great Obstetrical Syndromes"

Pediatr Endocrinol Rev. 2015 Dec;13(2):546-58.

Abstract

In neonatal medicine, nutritional research is focusing more and more on thrifty phenotype effects, in order to understand and prevent the development of long-term diseases. lschemic placental disease which brings together Gestational diabete, Preeclamptic Toxemia, and Intrauterine Growth Restriction, the "Great Obstetrical Syndromes" (GOS), originates from sugar.and lipid metabolism. Adipokines and metabolomics can be valuable tools for the diagnosis of obstetrical syndromes and addressing nutrition. Inappropriate nutrition, even in the first periods of life, can accelerate the development of chronic metabolic diseases, especially in the pediatric age. The purpose of this review is firstly to critically examine the information provided by the studies of metabolomics on GOS's and better understand their origin. Secondly, it reflects on the IUGR metabolism and on applications of metabolomics in nutrition and its "nutrimetabolomic" effects and then to discuss the principles that guide nutrition of IUGR children in the light of these.

Publication types

  • Review

MeSH terms

  • Adipokines*
  • Diabetes, Gestational
  • Dysbiosis
  • Female
  • Fetal Growth Retardation
  • Humans
  • Infant Nutritional Physiological Phenomena
  • Infant, Newborn
  • Insulin Resistance
  • Metabolomics*
  • Milk, Human
  • Obesity
  • Pre-Eclampsia
  • Pregnancy
  • Pregnancy Complications*
  • Syndrome

Substances

  • Adipokines